No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
TRVN Trevena
- 0.3910
- -0.0180-4.40%
Close Apr 26 16:00 ET
- 0.3910
- 0.00000.00%
Post 18:57 ET
7.16MMarket Cap-123P/E (TTM)
0.4090High0.3835Low46.62KVolume0.3978Open0.4090Pre Close18.52KTurnover0.26%Turnover RatioLossP/E (Static)18.32MShares3.280052wk High-0.94P/B7.08MFloat Cap0.300152wk Low--Dividend TTM18.10MShs Float339.2500Historical High--Div YieldTTM6.24%Amplitude0.3001Historical Low0.3970Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
12 Health Care Stocks Moving In Friday's Pre-Market Session
GainersChromocell Therapeutics (AMEX:CHRO) stock increased by 21.6% to $1.49 during Friday's pre-market session. The company's market cap stands at $8.7 million. Kineta (NASDAQ:KA) stock moved upwards
12 Health Care Stocks Moving In Thursday's Pre-Market Session
GainersBio-Path Hldgs (NASDAQ:BPTH) shares increased by 43.8% to $4.66 during Thursday's pre-market session. The market value of their outstanding shares is at $3.5 million. SINTX Techs (NASDAQ:SINT)
12 Health Care Stocks Moving In Wednesday's After-Market Session
GainersTrevena (NASDAQ:TRVN) shares increased by 27.0% to $0.51 during Wednesday's after-market session. The company's market cap stands at $9.2 million. Mustang Bio (NASDAQ:MBIO) stock increased by 1
Trevena Is Maintained at Buy by HC Wainwright & Co.
Trevena Is Maintained at Buy by HC Wainwright & Co.
Express News | HC Wainwright & Co. Maintains Buy on Trevena, Maintains $9 Price Target
Buy Rating Affirmed on Trevena as Focus Shifts to Promising Drug Candidate TRV045
Comments
$Trevena(TRVN.US$ Patent news!
3
Biopharmaceutical Company Makes Headlines For Potential New Drug
The Future of Postoperative Pain: Trevena's Oliceridine.
The world of medicine is constantly evolving, and one company at the forefront of this evolution is Trevena, Inc. (NASDAQ: $TRVN). A biopharmaceutical company with a focus on developing innovative therapies, Trevena recently made headlines with the publication of their research in the PLOS ONE journal. The study, titled "Efficacy, safety, and side effects of oliceridine in acu...
The world of medicine is constantly evolving, and one company at the forefront of this evolution is Trevena, Inc. (NASDAQ: $TRVN). A biopharmaceutical company with a focus on developing innovative therapies, Trevena recently made headlines with the publication of their research in the PLOS ONE journal. The study, titled "Efficacy, safety, and side effects of oliceridine in acu...
$Trevena(TRVN.US$ good news, can this run hard?
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
Stocksgoup : what news?
Greg SarantopoulosOP : Stock twits had some news that someone posted.
Greg SarantopoulosOP : check about 30 mins ago in Stocktwits